Denemek ALTIN - Özgür
GDP blitz at 7.6% lays ground for FY24 show
Mint Mumbai
|December 01, 2023
Mining, manufacturing, construction fuel Q2; core sector grows 12% in Oct
The Indian economy shot past expectations to clock an impressive 7.6% growth in the September quarter, retaining its crown as the world’s fastest-growing major economy. That’s a major step-up from 6.3% in the corresponding period of the previous fiscal year.
While manufacturing, mining and construction put up a robust show, agriculture cooled thanks to an erratic monsoon, National Statistical Office (NSO) data showed. The quarter saw double-digit growth in fixed investments and government spending, while household consumption rose marginally.
A Mint poll of 18 economists had estimated the gross domestic product (GDP) growth to be about 6.8% in the quarter.
The Indian economy expanded at 7.8% in the first quarter of the current fiscal year. The Reserve Bank of India’s (RBI) forecast for 2023-24 is 6.5%, while others like investment bank Goldman Sachs see a more sedate 6.2% growth.
Separately, the output data for eight core sector industries showed an increase of 12.1% in October against the previous year’s 0.7%, setting the stage for continued momentum in the December quarter as well.
With the 7.6% GDP growth in real terms in the September quarter, India is now comfortably set to achieve 6.5% growth in the current fiscal, chief economic advisor Anantha Nageswaran said. “We are more comfortable with 6.5% growth forecast for FY24 now," Nageswaran said at a briefing after the second quarter GDP figures were released by the statistics ministry.
India’s growth figures come at a time when major global economies are facing slowing growth and steep interest rates. The International Monetary Fund (IMF) has predicted that the Indian economy will outperform Indonesia (4.93%), China (4.9%), the US (2.93%), Japan (1.2%), France (0.69%), the UK (0.62%) and Germany (-0.37%) in the September quarter.
Bu hikaye Mint Mumbai dergisinin December 01, 2023 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Mint Mumbai'den DAHA FAZLA HİKAYE

Mint Mumbai
Tata Trusts strife bares a void
Today's meeting may set the tone for the philanthropic entities' future, a year after the death of Ratan Tata
4 mins
October 10, 2025
Mint Mumbai
Silver ETFs fired up by scarcity, festivals
Silver exchange traded funds or ETFs opened Thursday with a record 10-12% premium to spot prices, underscoring a scramble for the metal as festive buying, industrial use, and investor FOMO (fear of missing out) drove up demand against tight supplies.
2 mins
October 10, 2025
Mint Mumbai
AI BROKE THE INFO BOTTLENECK, BUT VALUE INVESTING STILL DEPENDS ON INSIGHT
In a Bloomberg column, Guy Spier argues that AI has ended the golden age of value investing by removing the old information edge.
2 mins
October 10, 2025

Mint Mumbai
TCS preps big pivot to AI, data centres
At least $6 bn investment in 6 yrs; Q2 revenue beats expectations
3 mins
October 10, 2025
Mint Mumbai
INDUSIND BANK RATED INDIA INVOLVED BY SKOCH FOR EXCELLENCE IN MSME BANKING
Once upon a spreadsheet, India's MSMEs were drowning in paperwork, late payments and queues that snaked through branch corridors like endless fiscal serpents.
2 mins
October 10, 2025

Mint Mumbai
Sunjay Kapur's will forged, ex-wife's children tell court
Dispute revolves around ₹30,000-cr estate contested between Kapur's kids and widow Priya
3 mins
October 10, 2025

Mint Mumbai
India to ease US trade barrier pressure for medical devices
The plan may include subsidies, mutual recognition pacts for easy acceptance of Indian items
2 mins
October 10, 2025
Mint Mumbai
Akasa co-founder Khatri exits after ₹1,200 cr funding
Ex-IAF officer's departure is the first from the founding team since the carrier's 2022 launch.
1 mins
October 10, 2025
Mint Mumbai
HC nod to Natco for generic Risdiplam
In a setback to Swiss pharma major Roche, the Delhi High Court has refused to restrain local drugmaker Natco Pharma from selling a generic version of lifesaving drug Risdiplam in India, upholding a March single-judge order.
1 mins
October 10, 2025

Mint Mumbai
Razorpay to enter four new markets in South-East Asia
Initial public offering (IPO)-bound fintech major Razorpay is planning to expand into three to four new South-East Asian markets by the end of 2026, the firm's top executive told Mint in an interaction.
1 mins
October 10, 2025
Translate
Change font size